This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Ratiopharm Gmbh. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Konstantin Holfinger: Innovator in Pharmaceutical Dosage Forms
Introduction
Konstantin Holfinger is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral dosage forms. His work focuses on improving the efficacy and delivery of essential medications.
Latest Patents
Holfinger holds a patent for a dosage form comprising lopinavir and ritonavir. This invention relates to an oral dosage form that includes crystalline lopinavir and crystalline ritonavir. The patent also covers methods for preparing these oral dosage forms containing the aforementioned pharmaceutical active agents. He has 1 patent to his name.
Career Highlights
Konstantin Holfinger is currently employed at Ratiopharm GmbH, a prominent pharmaceutical company known for its innovative healthcare solutions. His role involves research and development, where he applies his expertise to create effective pharmaceutical products.
Collaborations
Holfinger collaborates with various professionals in the industry, including his coworker Dominique Meergans. Together, they work on advancing pharmaceutical formulations and improving patient outcomes.
Conclusion
Konstantin Holfinger's contributions to the pharmaceutical industry, particularly through his patent on dosage forms, highlight his commitment to innovation in healthcare. His work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile